Markets:

Overview

News

Currencies

International

Treasuries

Biolase, Inc. - Common Stock (NQ:BIOL)

0.1290 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Biolase, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

December 03, 2021

Good morning, investor! We're at the end of the week and it starts off with the biggest pre-market stock movers for Friday!

Via InvestorPlace

20 Stocks Moving in Friday's Pre-Market Session ↗

December 03, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) rose 27.2% to $0.52 in pre-market trading. Biolase reporte in Form4 filing that President bought 70,000 shares at an average price of $0.45...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 68.43% to $17.18 during Friday's pre-market session. The market value of their outstanding shares is at $119.6...

Via Benzinga

48 Stocks Moving In Friday's Mid-Day Session ↗

November 26, 2021

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded...

Via Benzinga

25 Stocks Moving in Friday's Pre-Market Session ↗

November 26, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) rose 56.9% to $16.00 in pre-market trading. The company recently announced it has been contracted to support new advanced research on COVID-...

Via Benzinga

68 Biggest Movers From Wednesday ↗

November 26, 2021

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...

Via Benzinga

Topics Initial Public Offering

40 Stocks Moving In Wednesday's Mid-Day Session ↗

November 24, 2021

Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target. Longeveron Inc...

Via Benzinga

GAME Stock: 6 Reasons Why Engine Gaming and Media Investors Are Feeling Thankful Today ↗

November 24, 2021

Engine Gaming and Media (GAME) stock is on the move today as investors celebrate positive fiscal Q4 2021 earnings results.

Via InvestorPlace

BFRI Stock: 7 Things to Know About Biofrontera as Shares Rocket on $20 Price Prediction ↗

November 24, 2021

Biofrontera (BFRI) stock is catching the eyes of investors on Wednesday following a bullish price prediction and new rating.

Via InvestorPlace

BIOL Stock Alert: Why Little-Known BIOLASE Is Rocketing Higher Today ↗

November 24, 2021

Dental laser company BIOLASE is seeing its share price jump 20% higher after it was granted an extension by the Nasdaq exchange.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $107.6...

Via Benzinga

28 Stocks Moving in Wednesday's Pre-Market Session ↗

November 24, 2021

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 and FY21 revenue was higher year over year....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 24, 2021

We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 23, 2021

Gainers Biolase (NASDAQ:BIOL) shares incr...

Via Benzinga

Biolase's Earnings Outlook ↗

November 09, 2021

Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Biolase Earnings Perspective: Return On Invested Capital ↗

September 29, 2021

According to data from Benzinga Pro, during Q2, Biolase's (NASDAQ:BIOL) reported sales totaled $9.13 million. Despite a 45.84% increase in earnings, the company posted a loss of $...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 07, 2021

Gainers Cellectar Biosciences (NASDAQ:CLRB

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 23, 2021

Gainers Cara Therapeutics (NASDAQ:CARA) ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 17, 2021

Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock increased by 25.72% to $2.59 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

78 Biggest Movers From Friday ↗

August 16, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 13, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

Mid-Afternoon Market Update: Honest Co Falls After Q2 Results; Pilgrim's Pride Shares Jump ↗

August 13, 2021

Toward the end of trading Friday, the Dow traded up 0.03% to 35,510.30 while the NASDAQ fell 0.02% to 14,813.66. The S&P also rose, gaining 0.09% to 4,464.72. The U.S. has the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 13, 2021

Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for this security as of 12:35 EST is 80.8 million,...

Via Benzinga

Mid-Day Market Update: Gold Rises Over 1%; Duos Technologies Shares Plummet ↗

August 13, 2021

Midway through trading Friday, the Dow traded up 0.07% to 35,525.67 while the NASDAQ rose 0.03% to 14,821.05. The S&P also rose, gaining 0.07% to 4,463.78. The U.S. has the...

Via Benzinga

Topics Stocks

53 Stocks Moving In Friday's Mid-Day Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...

Via Benzinga

Biolase Stock Is Trading Higher On Better Than Expected Q2 Earnings ↗

August 13, 2021

Biolase Inc (NASDAQ: BIOL) shares are trading higher on strong volume after it reported Q2 sales of $9.1 million, +211% Y/Y, edging out a consensus of $8.31 million....

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 13, 2021

Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

30 Stocks Moving in Friday's Pre-Market Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares rose 32.9% to $0.839 in pre-market trading after the company reported better-than-expected Q2 sales. The company said it continues to...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Biolase, Inc. - Common Stock (NQ:BIOL)

Headline News about Biolase, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today